Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Around here we like to take a little breather after distributing the quarterly Trend Analysis; response to the 2Q10 report has been very positive – many thanks – now it is time to get back after it, so expect to see the 3Q10 deals come barreling in starting next week. Now for informal poll time…With […]

Hot off the press! The 2Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 2Q10 OnBioVC Trend Analysis tracked, in aggregate, 81 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,664.2M. Compared to 1Q10 OnBioVC data, this investment activity represents an increase in the […]

It is always an exciting opportunity to report on new fund closings. In this case you may have already heard of Boston-based SV Life Sciences who recently closed their oversubscribed (yes, oversubscribed its $400M target close by some $100M+) $523M Fund V. A few years ago I met peHub Editor-at-Large extraordinaire Dan Primack, who went […]

“It is not birth, marriage or death but gastrulation, which is truly the most important time in your life.” – Lewis Wolpert UPDATE OnBioVC, an Indicium Data company, is excited to announce that a satellite office has opened at Harvard Square in Cambridge, MA! If you are in the neighborhood (or anywhere in the greater […]

NEW FUNDS Not much to report on in terms of new bioscience fund closings however, something to keep an eye on is the planned reported estimated $250M HealthCare Ventures Fund IX whose Form D was filed last week. GOT CASH? If you have not been paying attention lately, perhaps this will jar something loose $1BILLION […]

Hot off the press! The 1Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 1Q10 OnBioVC Trend Analysis tracked, in aggregate, 74 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,260.1M. Compared to 1Q09 OnBioVC data, this investment activity represents a decrease in the […]

Veryan (United Kingdom) a clinical-stage medical device company focused on a three dimensional vascular stent for peripheral vascular disease, closed a $5.4M series B financing. Participants include Seroba Kernal, Imperial Innovations, Oxford Capital Partners and NESTA.

The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation. Is it just me or are there some mixed signals here? Is the sky falling, LP’s running for the exits and new capital simply a figment of the imagination or did Boston-based […]

Kosmos Biotherapeutics (Cambridge, MA) a preclinical-stage biopharmaceutical company developing an astrobiological therapeutic platform focused on the treatment of post-evolutionary disease in zero-gravity celestial settings, closed a whopping $319M Series A financing. Participants include Apple Ventures, Omniscient Venture Partners, Clairvoyant Capital, NASA Bioventures and Crystal Ball Ventures. _________________________________________________________________________ Wishing you a happy April Fool’s And no […]

Some interesting news out of the backyard here in Boulder, Colorado is that Nobel Prize winner Tom Cech, Ph.D. has been appointed as Special Advisor to the Morgenthaler Ventures Life Science Team, assisting Partners in the identification and review of new investment opportunities. Dr. Cech stepped down as President of the Howard Hughes Medical Institute […]

The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation. There is not too much detail on this one however, it has been thinly reported that Avista Capital Partners has closed the new $1.8 billion Fund II. Taking a look at their […]

Thank you for the wonderful (and voluminous) feedback last week, I am still working my way through all of the email responses. If you have not heard from me yet, you will shortly. Today’s posts should yield the obvious…that is there was sufficient interest and enthusiasm to warrant continuation of the Friday Communiqué series, that […]

The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation. Last week OnBioVC reported on the new $550M OrbiMed Caduceus Fund IV. Today we welcome a new fund to the street that now puts 2010 newly formed capital in excess of the […]

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...